Next Article in Journal
The Infantile Leukoencephalopathy-Associated Mutation of C11ORF73/HIKESHI Proteins Generates De Novo Interactive Activity with Filamin A, Inhibiting Oligodendroglial Cell Morphological Differentiation
Previous Article in Journal
Acknowledgment to Reviewers of Medicines in 2020
Open AccessArticle

Prevalence of Upper Extremity Musculoskeletal Disorders in Patients with Type 2 Diabetes in General Practice

1
Department of Family Medicine, CAPHRI Care and Public Health Research Institute, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands
2
Ministry of Education, Riyadh 12435, Saudi Arabia
3
Department of Public Health and Primary Care, Catholic University of Leuven, Kapucijnenvoer 33, B-3000 Leuven, Belgium
4
Institute of General Practice, Goethe University, Frankfurt am Main, 60323 Frankfurt, Germany
5
Academic Centre for General Practice/Department of Public Health and Primary Care, KU Leuven, Naamsestraat 80, B-3000 Leuven, Belgium
6
Department of Methodology and Statistics, CAPHRI Care and Public Health Research Institute, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands
*
Author to whom correspondence should be addressed.
Received: 21 December 2020 / Revised: 14 January 2021 / Accepted: 18 January 2021 / Published: 1 February 2021
Background: One of the lesser recognized complications of diabetes mellitus are musculoskeletal (MSK) complications of the upper and lower extremity. No prevalence studies have been conducted in general practice. Thus, the aim of this study was to investigate the prevalence of upper extremity MSK disorders in patients with type 2 diabetes (T2DM) in the Netherlands. Methods: We conducted a cross-sectional study with two different approaches, namely a representative Dutch primary care medical database study and a questionnaire study among patients with T2DM. Results: In the database study, 2669 patients with T2DM and 2669 non-diabetes patients were included. MSK disorders were observed in 16.3% of patients with T2DM compared to 11.2% of non-diabetes patients (p < 0.001, OR 1.53, 95% CI 1.31, 1.80). In the questionnaire study, 200 patients with T2DM were included who reported a lifetime prevalence of painful upper extremity body sites for at least four weeks of 67.3%. Conclusion: We found that upper extremity MSK disorders have a high prevalence in Dutch patients with T2DM presenting in general practice. The prevalence ranges from 16% based on GP registered disorders and complaints to 67% based on self-reported diagnosis and pain. Early detection and treatment of these disorders may play a role in preventing the development of chronic MSK disorders. View Full-Text
Keywords: type 2 diabetes; musculoskeletal disorders; prevalence; diabetes complication type 2 diabetes; musculoskeletal disorders; prevalence; diabetes complication
MDPI and ACS Style

Alabdali, L.A.S.; Jaeken, J.; Dinant, G.-J.; van den Akker, M.; Winkens, B.; Ottenheijm, R.P.G. Prevalence of Upper Extremity Musculoskeletal Disorders in Patients with Type 2 Diabetes in General Practice. Medicines 2021, 8, 8. https://0-doi-org.brum.beds.ac.uk/10.3390/medicines8020008

AMA Style

Alabdali LAS, Jaeken J, Dinant G-J, van den Akker M, Winkens B, Ottenheijm RPG. Prevalence of Upper Extremity Musculoskeletal Disorders in Patients with Type 2 Diabetes in General Practice. Medicines. 2021; 8(2):8. https://0-doi-org.brum.beds.ac.uk/10.3390/medicines8020008

Chicago/Turabian Style

Alabdali, Login A.S.; Jaeken, Jasmien; Dinant, Geert-Jan; van den Akker, Marjan; Winkens, Bjorn; Ottenheijm, Ramon P.G. 2021. "Prevalence of Upper Extremity Musculoskeletal Disorders in Patients with Type 2 Diabetes in General Practice" Medicines 8, no. 2: 8. https://0-doi-org.brum.beds.ac.uk/10.3390/medicines8020008

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop